Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …

Acinetobacter baumannii is an opportunistic bacterial pathogen that causes severe
infections in immunocompromised individuals. A. baumannii forms biofilm and produces …

The rapid emergence of multidrug-resistant pathogens makes an urgent need for
discovering novel antimicrobial agents as alternatives to conventional antibiotics. Towards …

Antimicrobial peptides (AMPs) have become a key solution for controlling multi-drug-
resistant (MDR) pathogens, and the nanoencapsulation of AMPs has been used as a …

Most clinically isolated Candida albicans strains are drug-resistant, emphasizing the urgent
need to discover alternative therapies. In this study, the previously characterized Octominin …

Acinetobacter baumannii is one of the most challenging pathogens, on account of its
predisposition to develop resistance leading to severe, difficult-to-treat infections. As these …

The rapid emergence of antimicrobial resistance in Acinetobacter baumannii coupled with
the dried pipeline of novel treatments has driven the search for new therapeutic modalities …

Multidrug-resistant Acinetobacter baumannii has recently emerged as an important
pathogen in nosocomial infection; thus, effective antimicrobial regimens are urgently …

Background With the increasing rate of antibiotic resistance in Acinetobacter, the World
Health Organization introduced the carbapenem-resistant isolates in the priority pathogens …

The increasing prevalence of drug-resistant pathogens highlights the need to identify novel
antibiotics. Here we investigated the efficacies of four new antimicrobial peptides (AMPs) for …